technewslit, A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.
https://sciencebusiness.technewslit.com/?p=45448
#News #Press #Science #Business #Regulatory #ClinicalTrial #Biotechnology #UK #Germany #mRNA #Lungs #Respiratory #Inhaled #Lipid #Nanoparticles #Immune
Add comment